ADX10059 Migraine Prevention Study

Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine

NCT03939312 ·Status: COMPLETED ·Phase: PHASE3

A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine

NCT04686136 ·Status: COMPLETED ·Phase: PHASE3

Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

NCT06241313 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

NCT06323928 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention

NCT03238781 ·Status: COMPLETED ·Phase: PHASE2

Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study

NCT04084314 ·Status: COMPLETED ·Phase: PHASE4

The Prolonged Use of Topiramate for Preventing Migraine Headaches

NCT00216619 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine

NCT03700320 ·Status: COMPLETED ·Phase: PHASE3

Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine

NCT05861427 ·Status: COMPLETED ·Phase: PHASE3

Efficacy, Safety, and Tolerability of Atogepant for the Prevention of Chronic Migraine

NCT03855137 ·Status: COMPLETED ·Phase: PHASE3

Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine

NCT05707949 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3

Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine

NCT06806293 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Randomized Trial in Adult Participants With Acute Migraines

NCT04571060 ·Status: COMPLETED ·Phase: PHASE3

An Acute Migraine Factorial Study

NCT06245902 ·Status: COMPLETED ·Phase: PHASE2

A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic Migraine

NCT04437433 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine

NCT05264129 ·Status: COMPLETED ·Phase: PHASE4

Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan

NCT05064371 ·Status: COMPLETED ·Phase: PHASE3

Open Label, 6-month Study for High Frequency and Chronic Migraine,

NCT06133491 ·Status: ACTIVE_NOT_RECRUITING

Chordate System S020 Acute Migraine Clinical Investigation

NCT02185703 ·Status: TERMINATED ·Phase: NA

An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants

NCT05653986 ·Status: COMPLETED

Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine

NCT06543914 ·Status: RECRUITING

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

NCT02867709 ·Status: COMPLETED ·Phase: PHASE3

Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine

NCT07159750 ·Status: RECRUITING

A Study in Migraine Prevention

NCT01184508 ·Status: TERMINATED ·Phase: PHASE2

To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients

NCT02542605 ·Status: COMPLETED ·Phase: PHASE1